TARA
Protara Therapeutics Inc
3.40$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -20.4% | -35.6% | +1.1% | -46.5% | -70.3% | +2,812.6% | -15.0% | -34.4% | -30.3% | +129.8% | +15.4% | |
| – | -21.3% | -35.8% | +1.7% | -46.6% | -70.0% | +2,329.2% | -45.0% | -7.5% | -20.2% | +150.6% | -7.3% | |
| – | -41.8% | -9.1% | -41.8% | -8.5% | -68.1% | +2,627.7% | -78.8% | -32.5% | +64.1% | +311.3% | -69.5% | |
| – | -21.9% | -36.7% | +2.0% | -48.1% | -71.7% | +2,627.7% | -45.9% | -7.5% | -22.3% | +159.7% | -8.7% | |
| – | – | – | – | – | – | – | – | -23.3% | -50.2% | – | – | |
| – | – | – | – | – | – | – | – | -4.3% | – | – | – | |
| – | +169.9% | +66.1% | -30.4% | +1.5% | +74.5% | +170.2% | +616.9% | -11.5% | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | -99.7% | +3,067.9% | +21.9% | -9.7% | |
| – | +76.8% | +22.9% | +81.9% | -66.7% | -81.1% | +571.4% | +172.9% | +4.9% | -5.1% | +34.7% | -8.8% | |
| – | +76.8% | +22.9% | +81.9% | -66.7% | -81.1% | +400.0% | +47.4% | +33.6% | +7.1% | +78.3% | -0.2% | |
| – | – | – | – | – | – | – | +871.6% | +7.3% | +7.2% | +14.3% | +10.5% | |
| – | +11.2% | -45.5% | -98.6% | +5,370.1% | +62.4% | +27.7% | +4.4% | +66.2% | +53.5% | +82.0% | -21.7% | |
| – | -23.1% | -39.4% | -9.6% | -41.2% | -68.7% | +3,017.1% | -18.7% | -37.0% | -33.1% | +144.6% | +17.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +26.2% | +0.6% | +4.3% | +492.9% | +58.7% | +78.1% | +55.3% | +0.2% | +0.6% | +81.7% | +108.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.